Xybion Digital announced that it is partnering with a Global Pharmaceutical Company headquartered in Japan to streamline, digitize and optimize their drug stability study program to enhance process efficiency and improve compliance. Xybion's Labwise XD LIMS solution will help manage their stability studies in-house as well as conducted by their outsourced partners. Stability studies are becoming extremely important with various complex regulatory needs globally.

Global pharmaceutical companies need robust, yet flexible, stability studies programs that can be managed in their internal labs and can be extended to their outsourced partners as required. Labwise XD LIMS is a modular, unified, and all-inclusive end-to-end LIMS SaaS platform to support all workflows in the labs. This manages Test Methods, Sample Management, Stability Studies protocols, Inventory Management, Analytical Methods, Instrument Management, Lab Personnel Training, Quality Management, and lab Personnel Safety.

This helps create a unified Digital Lab Execution System and provides health & safety shields to lab personnel. This comes with a Customer Portal that helps create a seamless communication mechanism between multiple partner companies without downloading information out of Labwise XD. Labwise XD is also available to manage Gene & Cell Therapy Labs and Manufacturing Operations.

Xybion has been named as one of the top 10 Laboratory Information Management System (LIMS) Solution providers by multiple publications.